CD69: from activation marker to metabolic gatekeeper

By Danay Cibrian, F. Sánchez‐Madrid. European Journal of Immunology, 2017

803 citations recorded by the source corpus.

CD69 is a membrane‐bound, type II C‐lectin receptor. It is a classical early marker of lymphocyte activation due to its rapid appearance on the surface of the plasma membrane after stimulation. CD69 is expressed by several subsets of tissue resident immune cells, including resident memory T (TRM) cells and gamma delta (γδ) T cells, and is therefore considered a marker of tissue retention. Recent evidence has revealed that CD69 regulates some specific functions of selected T‐cell subsets, determining the migration‐retention ratio as well as the acquisition of effector or regulatory phenotypes. Specifically, CD69 regulates the differentiation of regulatory T (Treg) cells as well as the secretion of IFN‐γ, IL‐17, and IL‐22. The identification of putative CD69 ligands, such as Galectin‐1 (Gal‐1), suggests that CD69‐induced signaling can be regulated not only during cognate contacts between T cells and antigen‐presenting cells in lymphoid organs, but also in the periphery, where cytokines and other metabolites control the final outcome of the immune response. Here, we will discuss new aspects of the molecular signaling mediated by CD69 and its involvement in the metabolic reprogramming regulating TH‐effector lineages.

Subfields: Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/114e47be0ffa69db2aa44389464bc546fef7dda3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

Citations in the corpus

Human T cell development, localization, and function throughout life (2018, background): “Although CD69 can be upregulated following T cell activation (Cibrian and Sanchez-Madrid, 2017), CD69+ memory T cells in tissues do not exhibit features of activation such as HLA-DR, CD38, or Kumar et al.”